Leishmaniasis treatment: update of possibilities for drug repurposing

Area of Science:

• Medical Parasitology
• Drug Discovery
• Public Health

Background:

• Leishmaniases are neglected tropical diseases caused by Leishmania parasites, posing a significant public health challenge.
• Current treatments for leishmaniasis are inefficient, have severe side effects, and contribute to drug resistance.
• There is a critical need for novel therapeutic strategies due to the lack of an effective vaccine.

Purpose of the Study:

• To review the potential of drug repurposing as a strategy for developing new anti-leishmanial treatments.
• To analyze the advantages of using approved drugs for leishmaniasis therapy.

Main Methods:

• Literature review of drug repurposing approaches for leishmaniasis.
• Analysis of existing drugs with potential anti-leishmanial activity.
• Evaluation of the cost-effectiveness and safety of repurposed drugs.

Main Results:

• Drug repurposing presents a viable strategy to overcome limitations of current leishmaniasis treatments.
• Utilizing existing drugs reduces the cost and time associated with drug discovery, as toxicity data is already available.
• This approach can accelerate the development of new therapies for neglected diseases.

Conclusions:

• Drug repurposing is a promising avenue for developing effective and accessible treatments for leishmaniasis.
• This strategy addresses the urgent need for new interventions against Leishmania parasites.
• Further research into drug repurposing holds significant potential for global health impact.